(Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of ...

Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...

Aker ASA's NAV discount persists, with concerns about oil market dynamics and Cognite's cash burn affecting value realization ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. While Beta Bionics ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Indobell Insulation’s IPO, worth ₹10.14 crore, was fully subscribed on its first day. The offering is priced at ₹46 per share ...

BR Goyal IPO opened for subscription on January 7 and closes on January 9. The ₹85 crore SME IPO is fully subscribed, with a ...